rs121913273
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.
|
22162589 |
2012 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
|
21430269 |
2011 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
|
19513541 |
2009 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
|
19513541 |
2009 |
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
|
19513541 |
2009 |
rs121913279
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
|
19513541 |
2009 |
rs121913279
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
A novel dual PI3Kalpha/mTOR inhibitor PI-103 with high antitumor activity in non-small cell lung cancer cells.
|
19513541 |
2009 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
|
19029981 |
2008 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
|
18725974 |
2008 |
rs104886003
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.
|
18725974 |
2008 |
rs104886003
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
|
19029981 |
2008 |